FSGEX
Price
$14.17
Change
-$0.32 (-2.21%)
Updated
Dec 18 closing price
MXJVX
Price
$8.71
Change
-$0.19 (-2.13%)
Updated
Dec 18 closing price
Ad is loading...

FSGEX vs MXJVX

Header iconFSGEX vs MXJVX Comparison
Open Charts FSGEX vs MXJVXBanner chart's image
Fidelity Series Global ex US Index
Price$14.17
Change-$0.32 (-2.21%)
VolumeN/A
CapitalizationN/A
Empower International Value Instl
Price$8.71
Change-$0.19 (-2.13%)
VolumeN/A
CapitalizationN/A
FSGEX vs MXJVX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FSGEX vs. MXJVX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSGEX is a Buy and MXJVX is a Sell.

FUNDAMENTALS
Fundamentals
FSGEX has more cash in the bank: 49.3B vs. MXJVX (1.23B). MXJVX pays higher dividends than FSGEX: MXJVX (3.72) vs FSGEX (2.77). FSGEX was incepted earlier than MXJVX: FSGEX (15 years) vs MXJVX (10 years). MXJVX is a more actively managed with annual turnover of: 18.00 vs. FSGEX (6.00). FSGEX (0) and MXJVX (0) have matching initial minimum investment requirements. FSGEX annual gain was more profitable for investors over the last year : 10.43 vs. MXJVX (8.36). FSGEX return over 5 years is better than : 25.86 vs. MXJVX (19.58).
FSGEXMXJVXFSGEX / MXJVX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence15 years10 years-
Gain YTD7.6428.03295%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets49.3B1.23B4,024%
Annual Yield % from dividends2.773.7275%
Returns for 1 year10.438.36125%
Returns for 3 years7.523.74201%
Returns for 5 years25.8619.58132%
Returns for 10 years54.02N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CCAP19.56-0.26
-1.31%
Crescent Capital BDC
RL227.93-3.73
-1.61%
Ralph Lauren Corp
CAKE50.39-0.97
-1.89%
Cheesecake Factory
APLT1.10-0.05
-4.35%
Applied Therapeutics
MBRX1.86-0.33
-15.07%
Moleculin Biotech